VSee Health, Inc. (VSEE)
NASDAQ: VSEE · Real-Time Price · USD
1.200
-0.030 (-2.44%)
Mar 21, 2025, 1:10 PM EDT - Market open

VSee Health Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for VSee Health stock has a target of 5.00, which predicts an increase of 316.67% from the current stock price of 1.20.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $5.00 $5.00 $5.00 $5.00
Change +316.67% +316.67% +316.67% +316.67%

Analyst Ratings

According to 1 stock analyst, the rating for VSee Health is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Mar '25
Strong Buy 1
Buy 0
Hold 0
Sell 0
Strong Sell 0
Total 1

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Maxim Group
Maxim Group
Strong Buy
Initiates
$5
Strong Buy Initiates $5 +316.67% Feb 24, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
10.29M
from 5.84M
Increased by 76.10%
Revenue Next Year
16.95M
from 10.29M
Increased by 64.83%
EPS This Year
n/a
from -0.34
EPS Next Year
n/a
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
6.80M7.34M6.38M5.84M10.29M16.95M22.05M
Revenue Growth
-7.82%-13.08%-8.42%76.10%64.83%30.03%
EPS
0.030.05-0.08-0.34---
EPS Growth
-82.03%-----
Forward PE
-------
No. Analysts ----333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026
High 10.6M 17.5M 22.7M
Avg 10.3M 17.0M 22.0M
Low 9.9M 16.3M 21.2M

Revenue Growth

Revenue Growth 202420252026
High
81.3%
69.7%
33.9%
Avg
76.1%
64.8%
30.0%
Low
69.2%
58.4%
24.9%

EPS Forecast

EPS
High
Avg
Low

EPS Growth

EPS Growth
High
Avg
Low
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.